SCHEMBL6965317

SCHEMBL6965317

O=C(O)C(Sc1ccccc1Cl)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.41
IDO1 P14902 1/20 0.41
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
POLB P06746 4/20 0.38
HSD17B10 Q99714 2/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 1/20 0.38
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 1/20 0.37
TERT O14746 1/20 0.36
MAPT P10636 1/20 0.36
KIF11 P52732 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11091141 0.82 ALDH1A1 (0.41) ALDH1A1PKMIDO1CES2CES1
SCHEMBL9849304 0.81 RXFP1 (0.49) ALDH1A1PKMIDO1POLB
SCHEMBL20448478 0.78 IDO1 (0.44) ALDH1A1IDO1POLBMEN1KMT2A
SCHEMBL6955752 0.78 TSHR (0.41) ALDH1A1PKMCES2CES1HSD17B10
SCHEMBL28130891 0.77 POLB (0.67) ALDH1A1PKMIDO1POLBHSD17B10
SCHEMBL6955616 0.76 POLB (0.41) POLBRAB9ASLC1A3SLC1A2SLC1A1
SCHEMBL7371155 0.75 ALDH1A1 (0.45) ALDH1A1HSD17B10MEN1KMT2AHPGD
SCHEMBL28131637 0.74 IDO1 (0.40) ALDH1A1PKMIDO1CES2CES1
SCHEMBL20563537 0.74 IDO1 (0.41) ALDH1A1IDO1POLBMEN1KMT2A
SCHEMBL6950806 0.73 LMNA (0.41) ALDH1A1POLBGAACYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed